Digital Content 
NEWS #PharmaBuzz
26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3033295/0/en/Inventiva-announces-the-publication-in-Biomedicine-Pharmacotherapy-of-the-results-from-a-preclinical-study-showing-improvement-of-portal-hypertension-with-lanifibranor-treatment.html
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/20/3030046/0/en/Inventiva-and-Hepalys-Pharma-Inc-announce-the-initiation-of-the-clinical-development-program-of-lanifibranor-in-Japan-with-the-dosing-of-the-first-participant-in-Phase-1-trial.html
29 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/29/3017552/0/en/Inventiva-announces-the-publication-of-the-results-from-the-investigator-initiated-proof-of-concept-clinical-trial-evaluating-lanifibranor-in-patients-with-T2D-and-MASLD-in-the-Jou.html
22 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/22/3013844/0/en/Results-of-LEGEND-evaluating-lanifibranor-in-combination-with-empagliflozin-in-MASH-selected-for-oral-presentation-at-the-upcoming-EASL-SLD-Summit-2025.html
15 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/15/2982240/0/en/Inventiva-will-present-data-from-the-final-analysis-of-the-Phase-2-study-evaluating-the-combination-of-lanifibranor-with-empagliflozin-in-patients-with-MASH-and-T2D-at-the-AASLD-Th.html
30 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/30/2972018/0/en/Inventiva-announces-the-positive-recommendation-of-the-fifth-DMC-of-the-NATiV3-Phase-3-clinical-trial-with-lanifibranor-in-patients-with-MASH.html
Share 